BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33992976)

  • 21. The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.
    Ming J; Liu W; Wu H; Li Y; Yang E; Wang Z; Xiao H; Quan R; Hu X
    Biomed Pharmacother; 2021 Aug; 140():111767. PubMed ID: 34058439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of potential Q-marker of traditional Chinese medicine based on plant metabolomics and network pharmacology: Periplocae Cortex as an example.
    Li ZT; Zhang FX; Fan CL; Ye MN; Chen WW; Yao ZH; Yao XS; Dai Y
    Phytomedicine; 2021 May; 85():153535. PubMed ID: 33819766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
    Yang J; Tian S; Zhao J; Zhang W
    Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory chemical constituents of Flos Chrysanthemi Indici determined by UPLC-MS/MS integrated with network pharmacology.
    Tian D; Yang Y; Yu M; Han ZZ; Wei M; Zhang HW; Jia HM; Zou ZM
    Food Funct; 2020 Jul; 11(7):6340-6351. PubMed ID: 32608438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a three-step-based novel strategy integrating DMPK with network pharmacology and bioactivity evaluation for the discovery of Q-markers of traditional Chinese medicine prescriptions: Danlou tablet as an example.
    Wang Q; Chen G; Chen X; Liu Y; Qin Z; Lin P; Shang H; Ye M; He L; Yao Z
    Phytomedicine; 2023 Jan; 108():154511. PubMed ID: 36334388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry and network pharmacology to reveal the key effective compounds and mechanism of Shengxian decoction for ameliorating doxorubicin cardiotoxicity.
    Jiao G; Wang Y; Song Y; Chen Y; Fan X; Zhao Q; Pang T; Zhang F; Chen W
    J Sep Sci; 2024 May; 47(9-10):e2300867. PubMed ID: 38726736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid identification and analysis of the active components of traditional Chinese medicine Xiaoxuming decoction for ischemic stroke treatment by integrating UPLC-Q-TOF/MS and RRLC-QTRAP MS
    Luo X; Chen X; Shen X; Yang Z; Du G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():313-322. PubMed ID: 31269467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationality of the ethanol precipitation process in modern preparation production of Zishui-Qinggan decoction evaluated by integrating UPLC-QTOF-MS/MS-based chemical profiling/serum pharmacochemistry and network pharmacology.
    Wu CY; Guo YY; Ma ZY; Zhou J; Long F; Shen H; Xu JD; Zhou SS; Huo JG; Hu CH; Li SL
    Phytochem Anal; 2024 Jun; 35(4):733-753. PubMed ID: 38219286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel and comprehensive strategy for quality control in complex Chinese medicine formula using UHPLC-Q-Orbitrap HRMS and UHPLC-MS/MS combined with network pharmacology analysis: Take Tangshen formula as an example.
    Wang X; Zhou W; Wang Q; Zhang Y; Ling Y; Zhao T; Zhang H; Li P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122889. PubMed ID: 34626904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The discovery of Q-markers of Qiliqiangxin Capsule, a traditional Chinese medicine prescription in the treatment of chronic heart failure, based on a novel strategy of multi-dimensional "radar chart" mode evaluation.
    He L; Liu Y; Yang K; Zou Z; Fan C; Yao Z; Dai Y; Li K; Chen J; Yao X
    Phytomedicine; 2021 Feb; 82():153443. PubMed ID: 33429210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cardioprotective Effects and Mechanisms of Astragalus-Safflower Herb Pairs on Coronary Heart Disease Identified by Network Pharmacology and Experimental Verification.
    Yuan Y; Liu H; Meng Q
    Front Biosci (Landmark Ed); 2023 May; 28(5):94. PubMed ID: 37258471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality evaluation of Compound Cheqian Tablets based on UPLC-Q-TOF-MS/MS, network pharmacology and "double external standards" QAMS].
    Wang K; Liu P; Wang SF; Zhang JY; Hu ZZ; Mei YQ; Yang YB; Wang ZT; Yang L
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(17):4675-4685. PubMed ID: 37802806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prediction of material basis and mechanism of Curcumae Rhizoma in treatment of coronary heart disease].
    Fei CH; Tong HJ; Li Y; Xu Z; Qin YW; Bian ZH; Su LL; Ji D; Lu TL; Mao CQ
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3270-3284. PubMed ID: 35851121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncovering the molecular mechanisms of Fructus Choerospondiatis against coronary heart disease using network pharmacology analysis and experimental pharmacology.
    Gao X; Zhang Y; Li T; Li J; Su Y; Wang H; Yan Z; Qin K
    Anal Biochem; 2023 Aug; 675():115214. PubMed ID: 37353066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated multicomponent analysis based on UHPLC-Q-Exactive Orbitrap-MS and network pharmacology to elucidate the potential mechanism of Baoyuan decoction against idiopathic pulmonary fibrosis.
    Zhang B; Gao D; Xu G; Zhu W; Liu J; Sun R; Wang L; Zhang C; Ding Q; Shi Y
    Phytochem Anal; 2022 Jul; 33(5):678-695. PubMed ID: 35396886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
    Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
    Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncovering the pharmacological mechanisms of Xijiao Dihuang decoction combined with Yinqiao powder in treating influenza viral pneumonia by an integrative pharmacology strategy.
    Guo R; Zhao M; Liu H; Su R; Mao Q; Gong L; Cao X; Hao Y
    Biomed Pharmacother; 2021 Sep; 141():111676. PubMed ID: 34126353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systems pharmacology-based mechanism exploration of Acanthopanax senticosusin for Alzheimer's disease using UPLC-Q-TOF-MS, network analysis, and experimental validation.
    Zhuo Y; Fu X; Jiang Q; Lai Y; Gu Y; Fang S; Chen H; Liu C; Pan H; Wu Q; Fang J
    Eur J Pharmacol; 2023 Sep; 954():175895. PubMed ID: 37422122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stepwise integrated multi-system to screen quality markers of Chinese classic prescription Qingzao Jiufei decoction on the treatment of acute lung injury by combining 'network pharmacology-metabolomics-PK/PD modeling'.
    Wang T; Lin S; Li H; Liu R; Liu Z; Xu H; Li Q; Bi K
    Phytomedicine; 2020 Nov; 78():153313. PubMed ID: 32866904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.